Biomarin Pharmaceutical (BMRN) Price to Sales (2010 - 2026)
Biomarin Pharmaceutical's (BMRN) Price to Sales stood at 3.25 in Q2 2026, down 5.6% from 3.45 a year earlier and down 3.5% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Price to Sales (2010 - 2026) Analysis & Trends
For FY2025, Biomarin Pharmaceutical's Price to Sales came in at 3.55, down 19.2% from FY2024.
- Annual Price to Sales has declined for three straight years.
- Across earlier years, Price to Sales came in at 4.39 in FY2024 (-41.5%), 7.52 in FY2023 (-18.3%), 9.20 in FY2022 (+4.5%) and 8.80 in FY2021 (+2.7%).
- The Q2 2026 figure is the lowest quarterly Price to Sales in data going back to Q1 2010.
- On a year-over-year basis, Price to Sales has declined for 13 consecutive quarters, with an average decline of 28.9% over the last eight quarters.
- Peak year-over-year performance for Price to Sales in the last five years was growth of 10.7% in Q1 2023, against a decline of 43.1% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 3.37 (Q1 2026), 3.55 (Q4 2025) and 3.36 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.25 |
| Mar 31, 2026 | 3.37 |
| Dec 31, 2025 | 3.55 |
| Sep 30, 2025 | 3.36 |
| Jun 30, 2025 | 3.45 |
| Mar 31, 2025 | 4.59 |
| Dec 31, 2024 | 4.39 |
| Sep 30, 2024 | 4.87 |
| Jun 30, 2024 | 6.05 |
| Mar 31, 2024 | 6.71 |
| Dec 31, 2023 | 7.52 |
| Sep 30, 2023 | 7.21 |
| Jun 30, 2023 | 7.30 |
| Mar 31, 2023 | 8.39 |
| Dec 31, 2022 | 9.20 |
| Sep 30, 2022 | 7.84 |
| Jun 30, 2022 | 8.04 |
| Mar 31, 2022 | 7.58 |
| Dec 31, 2021 | 8.80 |
| Sep 30, 2021 | 7.68 |
API Access
Biomarin Pharmaceutical Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();